| Nagy, Eszter (CEBINA 202003 CEO formerly Arsanis 201010– CSO + Co-founder before Intercell AG) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
CEBINA GmbH (Central European Biotech Incubator and Accelerator) |
Austria |
| Nahas, Nasri G. (Spinomix 201506 CEO before GeneBio CEO) |
Chief Executive Officer (CEO) |
Switzerland Innovation (Group) |
Switzerland |
| Nahavandi, Ali (Alna-Bioscience 201012 Managing Director + Founder) |
Managing Director |
Alna-Biscience GmbH & Co. KG |
Germany |
| Naheta, Akshay (SoftBank 201708 Managing Director of SoftBank Group International) |
Chief Executive Officer (CEO) |
SoftBank (Group) |
|
| Nahi, Yassin (Greater Geneva Bern area 202210 Director Life Sciences) |
Business Development Manager / Strategy Manager |
Greater Geneva Berne Area – Economic Development Agency (GGBa) |
Switzerland |
| Nakai, Yuta (Ajinomoto 202110 President of Ajinomoto Genexine) |
President/Director/Head Business Group/Unit/Division |
Ajinomoto (Group) |
Korea, Republic of |
| Nakamoto, Akira (Shimadzu 201504– Board Chairma before CEO) |
Board member, non-executive |
Shimadzu (Group) |
Japan |
| Nakamura, Koji (Chiome Bioscience 201710 Head Drug Discovery Labs before CEO of LivTech) |
Research & Development Manager |
Chiome Bioscience (Group) |
Japan |
| Nakao, Hiroshi (Yokogawa 202111 VP + Head of Life Business) |
President/Director/Head Business Group/Unit/Division |
Yokogawa (Group) |
Japan |
| Nakaya, Kazuya (Panasonic 201206 Executive Managing Director of Panasonic Healthcare Co., Ltd.) |
Managing Director |
PHC (Group) |
Japan |
| Nakayama, Joji (Daiichi Sankyo 201512 CEO) |
Chief Executive Officer (CEO) |
Daiichi Sankyo (Group) |
Japan |
| Nam, Kiyean (Qurient (KR) 201506 CEO) |
Chief Executive Officer (CEO) |
Qurient Co., Ltd. (KRX 115180) |
Korea, Republic of |
| Naményi, Christof (AXA 201208 Managing Director of AXA Private Equity) |
Managing Director |
Ardian (Group) |
France |
| Namouni, Fouad (BMS 201706 Head of Development Oncology) |
President/Director/Head Business Group/Unit/Division |
Bristol Myers Squibb (BMS) (Group) |
United States (USA) |
| Nara, Hitoshi (Yokogawa 202111 CEO) |
Chief Executive Officer (CEO) |
Yokogawa (Group) |
Japan |
| Naraghi, Mohammad (Siemens Medical Solutions 200603 Head of Business Development) |
Business Development Manager / Strategy Manager |
Siemens (Group) |
Germany |
| Naran, Raj (ALS Ltd 202107 CEO + Managing Director) |
Chief Executive Officer (CEO) |
ALS Ltd. (Group) |
Australia |
| Narasimhan, Vasant (Vas) (Novartis 201408– Global Head Developm Novartis Pharma before Global Head Developm Vaccines |
Research & Development Manager |
Novartis (Group) |
United States (USA) |
| Narayanan, Sabrina (Biofrontera 200801– Media-Scientific Expert before Galderma) |
n. a. |
Biofrontera (Group) |
Germany |
| Nash, Andrew (Zenyth 200602 CEO) |
Chief Executive Officer (CEO) |
CSL (Group) |
Australia |
| Nash, Duane (Immunic 202207 Board Chair) |
Board member, non-executive |
Immunic (Group) |
United States (USA) |
| Nastos, Aristotelis (North Rhine-Westphalia 202107 Head Life Sciences+Cleantech NRW.Bank before Creathor + NRW.Bank) |
Investment Manager |
Nordrhein-Westfalen (govt region) |
Germany |
| Natanek, Rafael (Gilde Investment 201903c– Partner at Gilde Healthcare before Bain Consulting) |
Partner (venture partner) |
Gilde Investment (Group) |
Netherlands |
| Nathrath, Daniel (Ada Health 201712 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Ada Health (Group) |
Germany |
| Natsias, Konstantinos (CAMAG 201302 CEO) |
Chief Executive Officer (CEO) |
CAMAG (Group) |
Switzerland |
| Nauck, Matthias (Univ Greifswald 201606 Professor + Baltic Analytics GmbH 201112 Managing Director) |
Managing Director |
Baltic Analytics GmbH |
Germany |
| Navabi, Stefanie (Biometra 200710) |
n. a. |
Endress+Hauser (Group) |
Germany |
| Naval, Jordi (InProTher 202102–Biocat 202003 CEO) |
Chief Executive Officer (CEO) |
InProTher ApS |
Denmark |
| Navid, Sasan (Virometix 202007 CFO before Amgen + Ernst & Young) |
Chief Financial Officer (CFO) |
Virometix AG |
Switzerland |
| Navon, Benjamin (W2O Group 201807) |
Public Relations Manager / Investor Relations Manager |
Real Chemistry (WeissComm Group) (Group) |
United States (USA) |
| Navot, Nir (Pronto Diagnostics 201010 CEO) |
Chief Executive Officer (CEO) |
Pronto Diagnostics Ltd. |
Israel |
| Nawana, Namal (Alere 201602 CEO) |
Chief Executive Officer (CEO) |
Abbott (Group) |
United States (USA) |
| Nazabal, Alexis (CovalX 200902 CEO) |
Chief Executive Officer (CEO) |
CovalX (Group) |
Switzerland |
| Neal, Leigh A. (Smart rTMS 202407 Founder + Medical Director) |
Company Founder |
Neurocare Group AG |
United Kingdom (GB) |
| Neal, Rodney (Körber 201703– VP Strategic Program Management at Werum IT Solutions America) |
Sales Manager / Marketing Manager |
Körber (Group) |
Germany |
| Nebel, Simon (Viopas Venture Consulting 202002 Founding Partner before Aravis 201401– Managing Partner + Founder) |
Managing Partner (investment firm) |
Aravis (Group) |
Switzerland |
| Nechansky, Andreas (Vela Laboratories 201107 COO) |
Chief Operating Officer (COO) |
Vela pharmazeutische Entwicklung und Laboranalytik GmbH (Vela Laboratories) |
Austria |
| Nederkoorn, Paul H. J. (Ostendum R&D BV 201401 CEO) |
Chief Executive Officer (CEO) |
Ostendum R&D B.V. |
Netherlands |
| Neeleman, Christiaan (Definiens 201309– COO before among others Philips Healthcare) |
Chief Operating Officer (COO) |
AstraZeneca (Group) |
Germany |
| Neerman, Haim (Variantyx 202404 CEO) |
Chief Executive Officer (CEO) |
Variantyx Inc. |
United States (USA) |
| Neermann, Jörg (Curexsys 202105– CEO before Life Sciences Partners Munich+ DVC + Atlas Venture) |
Chief Executive Officer (CEO) |
Curexsys GmbH |
Germany |
| Nehls, Michael C. (Ingenium 200604 CEO) |
Chief Executive Officer (CEO) |
Vivoryon (Group) |
Germany |
| Nehrbass, Ulf (Luxembourg Institute of Health 202402 CEO formerly Ksilink + QurlentTherapeutics + Institut Pasteur |
Chief Executive Officer (CEO) |
Luxembourg Institute of Health (LIH) |
Luxembourg |
| Neil, Madeleine (Uppsala BIO 201109 Director of Communications) |
Public Relations Manager / Investor Relations Manager |
Uppsala BIO |
Sweden |
| Neirinck, Dirk (Endress+Hauser 201510 Managing Director of Endress+Hauser Consult AG) |
Managing Director |
Endress+Hauser (Group) |
Switzerland |
| Neiss, Ursula |
n. a. |
Roche (Group) |
Germany |
| Nell, Peter (Mammoth Biosciences 202001c– CBO before Co-Founder of Casebia) |
Chief Business Officer (CBO) |
Mammoth Biosciences Inc. |
United States (USA) |
| Nelson, Todd R. (eBioscience 200708– CEO before Invitrogen + RBC Capital Markets + Merrill Lynch) |
Chief Executive Officer (CEO) |
Thermo Fisher (Group) |
United States (USA) |
| Nemeth, Balazs (IMMS GmbH 201406 Manager Bioanalytical + Biomedical Sensors) |
Researcher (university / research institute) |
Institut für Mikroelektronik- und Mechatronik-Systeme gGmbH (IMMS) |
Germany |
| Nerger, Matthias (Nordrhein-Westfalen (govt) 2008–201204 Head of BIO.NRW Office LEFT 4/12) |
Cluster Manager |
Nordrhein-Westfalen (govt region) |
Germany |
| Neri, Duccio (Philogen 201301 CEO) |
Chief Executive Officer (CEO) |
Philogen (Group) |
Italy |
| Nesmith, Ken (Lexent Bio 202006 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Roche (Group) |
United States (USA) |
| Nessi, Claudio (Omega Funds 202211 before NeoMed Management 201309) |
Investment Manager |
Omega Funds (Group) |
United States (USA) |
| Nestler, Klaus (Corporate Finance Partners 201402 Managing Director at CFP BioConnect AG) |
Managing Director |
Corporate Finance Partners (CFP) (Group) |
Germany |
| Nestmann, Judith (Bayer 201507 Investor Relations Manager) |
Public Relations Manager / Investor Relations Manager |
Bayer (Group) |
Germany |
| Nestorov, Peter (Scailyte 201901 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Scailyte AG |
Switzerland |
| Nettersheim, Michael (202009 ECBF General Partner before HTGF 200912 Investment Manager before MediGene AG) |
General Partner (venture partner) |
ECBF (European Circular Bioeconomy Fund) (Group) |
Germany |
| Netzer, Rainer (Evotec 200011–201503 SVP BusDev before Batelle Memorial Institute before Roche) |
Business Development Manager / Strategy Manager |
Evotec (Group) |
Germany |
| Netzer, Ravid (Scala Biodesign 202409 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Scala Biodesign (IL) |
Israel |
| Netzer, Tilo (PharmaLex 201401– Managing Director/COO joined 201206 before Merck Serono) |
Managing Director |
PharmaLex (Group) |
Germany |
| Neubauer, Gerd |
n. a. |
Industrie- und Handelskammer |
Germany |
| Neubauer, Gitte (Cellzome 2000 Founder) |
Company Founder |
GSK (Group) |
Germany |
| Neubauer, Peter (TU Berlin 201208 Prof at Institute of Biotechnology, FG Bioverfahrenstechnik) |
Professor |
Technical University Berlin (TU Berlin) |
Germany |
| Neubauer, Steffen (Omnilab 201204 Managing Director of Universal Laborservice GmbH) |
Managing Director |
Omnilab (DE) (Group) |
Germany |
| Neubeck, Peter (Kurma Partners 201901 Partner + Head of Munich Office before TVM Capital + Novartis + McKinsey) |
Partner (venture partner) |
Eurazeo (Group) |
Germany |
| Neuberger, Ralph (HUMAN Diagnostics 201402 Managing Director) |
Managing Director |
HUMAN Diagnostics Worldwide (Group) |
Germany |
| Neuefeind, Torsten (Proteros Biostructures 200610 Managing Director) |
Managing Director |
Proteros (Group) |
Germany |
| Neuer, Katja (MLM Medical Labs 202007 Director Business Development + Aquisgranainvest 2020205– Managing Director) |
Business Development Manager / Strategy Manager |
MLM Medical Labs (Group) |
Germany |
| Neugebauer, Julia (MorphoSys 202002 Director Corp Communications + IR) |
Public Relations Manager / Investor Relations Manager |
Novartis (Group) |
Germany |
| Neuhaus, Eckhart (Advalytix co-founder) |
n. a. |
Danaher (Group) |
Germany |
| Neuhaus, Gunther (Univ Freiburg 1999 Professor + Greenovation Biotech GmbH Co-founder) |
Professor |
University of Freiburg (Albert-Ludwigs-Universität Freiburg) |
Germany |
| Neujahr, Martin (Bruker Corp 201612 Head Bruker Detection CBRN business unit) |
President/Director/Head Business Group/Unit/Division |
Bruker (Group) |
Germany |
| Neukirch, Falk (Vita 34 201902 CFO) |
Chief Financial Officer (CFO) |
Vita 34 (Group) |
Germany |
| Neukom, Beat (Kuros Biosurgery 200808c– CFO before JnJ) |
Chief Financial Officer (CFO) |
Kuros (Group) |
Switzerland |
| Neuman, Toomas (IPDx Immunoprofiling Diagnostics GmbH 201511– Managing Director) |
Managing Director |
IPDx Immunoprofiling Diagnostics GmbH |
Germany |
| Neumann, Andreas (Boehringer 201510– Managing Director for HR joined 2011 as Head of Legal Dept + General Counsel) |
Human Resources Manager |
Boehringer Ingelheim (Group) |
Germany |
| Neumann, Birgit (Bayer Technology Systems 200503) |
n. a. |
Bayer (Group) |
Germany |
| Neumann, Björn (Monsanto 201304 Managing Director of Monsanto Agrar Deutschland GmbH) |
Managing Director |
Monsanto (Group) |
Germany |
| Neumann, Lars (Proteros 201305 VP Discovery Projects + Project Manager) |
n. a. |
Proteros (Group) |
Germany |
| Neumann, Peter G. (Rock Capital 202411 Managing Director) |
Managing Partner |
Rock Capital (Group) |
Germany |
| Neumüller, Dirk (Biotest 201608 Public Relations) |
Public Relations Manager / Investor Relations Manager |
Grifols (Group) |
Germany |
| Neusser, Marcus (Bio-Rad Laboratories GmbH 200512) |
n. a. |
Bio-Rad (Group) |
Germany |
| Neusüß, Christian (Hochschule Aalen 201001 Professor Chemistry) |
Professor |
Hochschule Aalen – Technik und Wirtschaft |
Germany |
| Neville, Lindsey (Consilium 201805) |
Public Relations Manager / Investor Relations Manager |
ICR (Group) |
United Kingdom (GB) |
| Newble, David (TTP Group 201506– Managing Director of TTP Labtech before CEO of TAP Biosystems) |
Managing Director |
SPT Labtech (Group) |
United Kingdom (GB) |
| Newell, William J. (Sutro Biopharma 201409 CEO) |
Chief Executive Officer (CEO) |
Sutro Biopharma Inc. (Nasdaq: STRO) |
United States (USA) |
| Newland, Andrew (Angle plc 201409 CEO + Founder) |
Chief Executive Officer (CEO) |
Angle plc (AIM: AGL) |
United Kingdom (GB) |
| Newman, Sondra S. (Repligen 202308 Global Head of Investor Relations) |
Public Relations Manager / Investor Relations Manager |
Repligen Corporation (Nasdaq: RGEN) |
United States (USA) |
| Ney, Ursula M. (Genkyotex 201105– CEO before Antisoma COO before Charterhouse Therapeutics CEO) |
Chief Executive Officer (CEO) |
Asahi Kasei (Group) |
Switzerland |
| Ng, Frankie (SGS –201505–202403 CEO STEPPED DOWN 3/24) |
Chief Executive Officer (CEO) |
SGS (Group) |
Switzerland |
| Ng, Michelle (Syngenta 202304 Head External Communications) |
Public Relations Manager / Investor Relations Manager |
Syngenta (Group) |
Switzerland |
| Nguyen, Anh (Medincell co-founder + Invitrogen co-founder) |
Company Founder |
MedinCell (Group) |
France |
| Nguyen, Tin (Monipol 202309 Managing Director) |
Managing Director |
Monipol (Group) |
Poland |
| Ni, Binhui (Ben) (BioLineRx 201708 CEO of iPharma) |
Chief Executive Officer (CEO) |
BioLineRx (Group) |
China |
| Nicholls, Anthony (OpenEye Scientific 202005 CEO + Founder) |
Chief Executive Officer (CEO) |
OpenEye Scientific (Group) |
United States (USA) |
| Nicholson, C. David (Bayer 201203– Head RnD at Bayer CropScience before Merck US + Schering-Plough + Organon) |
Research & Development Manager |
Bayer (Group) |
Germany |
| Nicholson, David (Allergan 201604 EVP + President Global Brands RnD) |
Research & Development Manager |
Allergan (Group) |
Ireland, Republic of |
| Nicholson, Jeremy (Murdoch Univ + ANPC 201909 Prof before Imperial College + MRC-NIHR Phenome Centre) |
Professor |
Murdoch University |
Australia |
| Nickisch, Klaus (Evestra 200808– Managing Director of Evestra GmbH) |
Managing Director |
Evestra (Group) |
Germany |
| Nickl, Wolfgang (Bayer 201804– CFO before ASML NV + Western Digital + Converge) |
Chief Financial Officer (CFO) |
Bayer (Group) |
Germany |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo.svg){kind=logo}
1 2 3 ... 57 58 59 ... 93 94 95 
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
